Le Lézard
Classified in: Health
Subjects: EXE, AVO

Four Leading Kratom Researchers Urge FDA To Focus On Science Rather Than Rhetoric


WASHINGTON, March 7, 2018 /PRNewswire-USNewswire/ -- Four of the world's leading kratom researchers today called on the U.S. Food and Drug Administration (FDA) to cease the agency's scientifically unsupported attacks on the coffee-like herb kratom. The scientists strongly believe that the current body of credible research on the actual effects of kratom demonstrates that it is not dangerously addictive, nor is it similar to "narcotics like opioids" with respect to "addiction" and "death" as stated by the FDA in its public advisories and subsequent warnings. It is the scientists' position that a ban on kratom could result in a "serious public health threat" as consumers are pushed to dangerous alternatives in the black market, while at the same time halting much needed scientific research on the risks and benefits of kratom and its alkaloids.

The four kratom experts organized today's news conference and were not paid to participate in it.  The scientists are: Marc T. Swogger, Ph.D., associate professor of psychiatry, University of Rochester Medical Center; Oliver Grundmann, Ph.D., clinical associate professor, College of Pharmacy, University of Florida; Paula N. Brown, Ph.D., director of applied research, BC Institute of Technology, Canada Research chair, Phytoanalytics and adjunct professor of biology, University of British Columbia; and Dr. Jack Henningfield, vice president of research, Health Policy and Abuse Liability, at PinneyAssociates, and adjunct professor of Behavioral Biology, Johns Hopkins University School of Medicine.

Instead of a de facto ban on kratom, the scientists urged the promotion of good manufacturing practices (GMP) complying to FDA standards, as is the case with other widely available supplements in the United States.

For the text of the four experts' statements, go to www.bit.ly/kratomscience.

EDITOR'S NOTE:  For more information, go to bit.ly/kratomscience, where a streaming audio recording of today's news event will be available online as of 4 p.m. ET/1 p.m. PT on March 7, 2018. Limited and unrestricted support for this news event is being provided by the nonprofit People Plants Health.

SOURCE Paula N. Brown, Ph.D., adjunct professor of biology, University of British Columbia


These press releases may also interest you

at 17:55
Valeo Pharma Inc. ("Valeo" or the "Company"), a Canadian pharmaceutical company, today announced the results of the matters submitted to shareholders at its annual meeting of shareholders held on April 25, 2024 (the "Meeting")....

at 17:43
Community Healthcare Trust Incorporated today announced that its Board of Directors has increased its common stock cash dividend for the quarter ended March 31, 2024. This dividend, in the amount of $0.46 per share, is payable on May 24, 2024 to...

at 17:31
DelveInsight's Urine Output Monitoring Systems Market Insights report provides the current and forecast market analysis, individual leading urine output monitoring systems companies' market...

at 17:00
Enghouse Video, a global leader in cutting-edge video technology solutions, today announced its partnership with SONIFI Health, enhancing virtual care in hospital settings. SONIFI Health is a leading U.S. healthcare technology company based in Sioux...

at 17:00
A record 3,618 graduating students and physicians matched to residency training programs in Canada in this year's R-1 Main Residency Match (R-1 match), the Canadian Resident Matching Service (CaRMS) announced today....

at 16:54
Hondros College of Nursing (HCN) will introduce a new Medical Assisting program at its six Ohio campuses in 2024 to meet the growing need for medical assistants in a variety of settings.  According to the U.S. Bureau of Labor Statistics (BLS),...



News published on and distributed by: